Cargando…
Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9
BACKGROUND: Tyroserleutide (YSL) inhibits the growth and metastasis of human hepatocellular carcinoma (HCC). This paper studied the effect of YSL on metastasis of human HCC and investigated its mechanisms. METHODS: In vivo, experimental lung metastasis models of human HCC SK-HEP-1 cells in nude mice...
Autores principales: | Che, Xuchun, Lu, Rong, Fu, Zheng, Sun, Yajun, Zhu, Zhi-feng, Li, Jin-ping, Wang, Song, Jia, Jing, Wang, Qing, Yao, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186774/ https://www.ncbi.nlm.nih.gov/pubmed/30349190 http://dx.doi.org/10.2147/DDDT.S177126 |
Ejemplares similares
-
Therapeutic Effects of Tyroserleutide on Lung Metastasis of Human Hepatocellular Carcinoma SK-HEP-1 and Its Mechanism Affecting ICAM-1 and MMP-2 and -9 [Retraction]
Publicado: (2023) -
Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation
por: Zhu, Zhi-feng, et al.
Publicado: (2008) -
In Vitro Effect of Cytokines, Inducers, and Inhibitors on the Secretion of MMP-2 and MMP-9 in Hepatocarcinoma Cell Line SK-Hep-1
por: Roomi, M. Waheed, et al.
Publicado: (2019) -
Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
por: Ma, Chenjun, et al.
Publicado: (2021) -
Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions
por: dos Santos, Jéssica Cavalcante, et al.
Publicado: (2018)